Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 1991

Primary Completion Date

January 31, 1995

Study Completion Date

January 31, 2008

Conditions

Acute Myeloid Leukemia

Interventions

DRUG

Busulfan

See Detailed Description section for description of treatment plan.

DRUG

Cyclophosphamide

See Detailed Description section for description of treatment plan.

DRUG

Mesna

See Detailed Description section for description of treatment plan.

Trial Locations (1)

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors

lead

St. Jude Children's Research Hospital

OTHER